Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
TRVI on Nasdaq
Farrell Simon - trading volume in the past year for Trevi Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
76.9K |
$550K |
$7.15 |
Mar 10, 2025 |
Direct |
|
|
| Performance Stock Option (right to buy) |
110K |
|
|
May 31, 2025 |
Direct |
Common Stock |
|
| Stock Option (right to buy) |
18.8K |
|
|
Mar 10, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.